Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DLJQ42
|
|||
| Drug Name |
MB-107
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Severe combined immunodeficiency [ICD-11: 4A01.10] | Phase 1/2 | [1] | |
| Company |
Mustang Bio; St. Jude Children's Research Hospital
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04887298) Study of Liposomal Annamycin for the Treatment of Subjects With Soft-Tissue Sarcomas (STS) With Pulmonary Metastases. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.